Publication:
Cytotoxicity and QSAR study of (thio)ureas derived from phenylalkylamines and pyridylalkylamines

dc.contributor.authorPingaew R.
dc.contributor.authorTongraung P.
dc.contributor.authorWorachartcheewan A.
dc.contributor.authorNantasenamat C.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:32:52Z
dc.date.available2021-04-05T03:32:52Z
dc.date.issued2013
dc.date.issuedBE2556
dc.description.abstractSimplified 1,3-disubstituted urea derivatives (11-24) of phenylethylamines, homoveratylamines, 2-pyridylethylamines, 2-picolylamines as well as xylylenediamines were synthesized and investigated for their cytotoxic activities. The results revealed that most analogs displayed cytotoxicity against HepG2 and MOLT-3 cell lines. The bis-thiourea derivatives 23 and 24 exhibited higher inhibitory potency against HepG2 cell than the reference drug, etoposide. 1,1′-(1,3-phenylenebis(methylene))bis(3-(4-chlorophenyl) thiourea) 24 was shown to be the most potent cytotoxic compound against MOLT-3 cell line with an IC50 value of 1.62 μM. QSAR studies suggested that compounds with high ionization potential displayed high cytotoxicity against HuCCA-1 cell line. Furthermore, derivatives with dimethoxyphenyl group had high radial distribution function with a correspondingly high cytotoxicity against A549 cell line. Moreover, analogs 23 and 24 had low values of E HOMO (energy of the highest occupied molecular orbital energy) as well as high cytotoxicity against HepG2 cell line. This study affords an easily accessible approach for the synthesis of promising anticancer agents. The developed QSAR models provided pertinent information into the physicochemical properties governing the investigated biologic properties. © 2012 Springer Science+Business Media New York.
dc.format.mimetypeapplication/pdf
dc.identifier.citationMedicinal Chemistry Research. Vol 22, No.8 (2013), p.4016-4029
dc.identifier.doi10.1007/s00044-012-0402-6
dc.identifier.issn10542523
dc.identifier.other2-s2.0-84879501042
dc.identifier.urihttps://hdl.handle.net/20.500.14740/6604
dc.rights.holderScopus
dc.subject.otherAnticancer
dc.subject.otherMultiple linear regression
dc.subject.otherQSAR
dc.subject.otherUrea
dc.subject.otherAliphatic amine
dc.subject.otherAntineoplastic agent
dc.subject.otherDoxorubicin
dc.subject.otherEtoposide
dc.subject.otherHomoveratylamine derivative
dc.subject.otherPhenylalkylamine
dc.subject.otherThiourea derivative
dc.subject.otherUnclassified drug
dc.subject.otherXylylenediamine derivative
dc.subject.otherArticle
dc.subject.otherCancer cell culture
dc.subject.otherCarbon nuclear magnetic resonance
dc.subject.otherCell strain HepG2
dc.subject.otherControlled study
dc.subject.otherCytotoxicity
dc.subject.otherDrug potency
dc.subject.otherDrug synthesis
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherIonization
dc.subject.otherProton nuclear magnetic resonance
dc.subject.otherQuantitative structure activity relation
dc.subject.otherQuantum chemistry
dc.titleCytotoxicity and QSAR study of (thio)ureas derived from phenylalkylamines and pyridylalkylamines
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84879501042&doi=10.1007%2fs00044-012-0402-6&partnerID=40&md5=e357cf12dc739997995a9a101f9a459d

Files